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Summary: A rapid and sensitive high perfbrmance liquid Chromatographie method was developed for Separation and
quantitation of acetaminophen, salicylic acid and salieyluric acid in human plasma and urine. The method involved
ethyl acetate extraction of the three drugs from plasma or urine followed by evaporation of the organic solvent phase
and dissolution of the residue in 100 methanol. A 20 aliquot was analysed on a reversed phase column using an
isocratic System of 60 ml/l acetonitrile in 4 mmol/1 phosphate buffer, pH 5.7 äs a mobile phase and a variable wave
length UV detector se\ at 237 nm. The procedure was used to determine the amounts of the three compounds in
plasma and urine of two healthy volunteers who ingested 650 mg of aspfrin® followed one hour later by 650 mg of
acetaminophen.
Untersuchungen zur simultanen Bestimmung von Acetaminophen, Salicylsäure und Salicylursäure in biologischen
Flüssigkeiten mit Hochleistungsflüssigchromatographie
Zusammenfassung: Zur Trennung und quantitativen Bestimmung von Acetaminophen, Salicylsäure und Salicylur-
säure im menschlichen Plasma und Harn wurde eine schnelle und empfindliche hochleistungsflüssigchromatographi-
sche Methode entwickelt. Die drei Pharmaka werden mit Ethylacetat aus Plasma oder Harn extrahiert, das Lösungs-
mittel abgedunstet und der Rückstand in 100 Methanol gelöst. Ein Aliquot von 20 wird an einer „reversed
phase "-Säule mit einem isokfatischen System von 60 ml/l Acetonitril in 4 mmol/1 Phösphatpuffer pH 5,7 als mobiler
Phase und einem ÜVJDetektor ( = 237 nm) analysiert.
Das Verfahren wurde zur Bestimmung der drei Verbindungeil in Plasma und Harn zweier gesunder Probanden, die
650 mg Aspirin® und eine Stunde später 650 mg Acetaminophen eingenommen hatten, eingesetzt.
n ro uc on We hypothise that co-administration of acetaminophen
Acetaminophen and salicylates are the most common and salicylates, especially for prolonged periods, may
drugs used äs analgesics and antipyretics. Although these cause competitive Inhibition of ghicurpnidation of
are supposed to be given ängly, thefe are many cpm- acetaminophen. Saturation of this pathway may result
mercial prpducts available which contain bpth in a in shunting to other pathways with formation of toxic
single dpsage form. In order to achieve a rapid therapeu- metabolites of acetaminophen which may lead to hepato-
tic effeet without the risk of chronic sälicylism, physi- cellular death (3).
cians preseribe these drugs in a eömbined, alternate ^^ ^ hazard from combination of both drugs
dosage regimen. prömpted us to develpp a simple and rapid method for
Alteration of the mode of biotransformation of acet- Separation and quantitation of both drugs and their
ammpphen by other drugs has been weU documented. metabolites in biological fluids.
Houston & Levy (1) dempnstrated that ascorbic acid,
admintetered in conjunction with acetaminophen, A number of spectrophotometric (5-7) methods used
agnificantly reduces the excretion rate of acetamino- for detection and quantitation of these drugs, can detect
phen sulfate. Levy et al. (2) demonstrated that salicyl- <** one ̂ 8 when both m Present· Mso> they m
amide competitively -inhibits the glucuronidatipn and insensitive and time consuming. Gas-liquid chromato-
sulfate corijugation of acetaminophen. g^Phic methods have been used for determination and
lNP tl—-—' ., _. . . . , _ . T<T . .. quantitation of acetaminophen (8,9), and salicylatesa) Fellow from the Pediatnc Department, Tanta ümversity, / r ·*· j · · u
Tarita, Egypt. -Research supported by the Agency for Inter- (10, 11). These methods are sensitive and specific, how-
national Development, U^.A.
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ever, chemical derivatisation is necessary. Hence, they
are time consuniing and require high technical experi-
ence.
High performance liquid Chromatographie methods
(12-14) were used for determination of acetaminophen
alone. Other HPLC methods (15-19) were used for
determination of salicylic acid and/or salicyluric acid.
There is only one HPLC method (20) that determined
both acetaminophen and salicylic acid simultaneöüsly.
However, the close and short retention times of acet-
aminophen and salicylic acid (2.15 and 2.90 min respect-
ively) prevented the complete Separation of both com-
pounds from each other and from other biological com-
pounds.
We describe in this report a reliable method for simul-
taneous quantitative determination of acetaminophen,




A liquid Chromatographie System (Waters Associates, Inc., Mil-
ford, Massachusetts 01757) consisted of models 6000A and
M45 pumps, model 720 System Controller, model 730 data
module and an automatic sample injector model 71 OB "WISP"
(Waters Intelligent Sample Processor). The effluent was moni-
tored by UV variable wave length detector (Beckman model 155,
Berkeley, California 94710). Separation was accomplished using
a Waters Bondapak C18 column, 3.9 mm i.d. X 30 cm con-
taining 10 particles of octadecylsilane-bonded spherical
silica. Water and solvents were filtered with Gelman 0.2
filters and degassed under vaccum prior to use.
Reagents
Acetaminophen (4-acetamidophenol, 98%), sodium salicylate
(99%) and salicyluric acid (o-hydroxyhippuric acid, 97%) were
purchased from Aldrich Chemical Company, Inc., (Milwaukee,
Wisconsin 53233). Ethyl acetate (HPLCgrade) was obtained
from Fisher Scientific Company (Fair Lawn, New Jersey 07410).
Acetonitrile (HPLC grade) was purchased from Burdic & Jack*
son Laboratories, Inc., (Muskegon, Michigan 49442). Other
chemicals and reagents were of the highest purity available and
were obtained from various commercial sources.
Analytical.procedures
Extraction
100 of pläsma or urine was diluted to 1.0 ml with distilled
water after adjusting pH of pläsma to 2.0 and pH of urine to
5.0. Fifteen ml of ethyl acetate and 4 g sodium Chloride were
added to the pläsma or urine in 40 ml volume glass tube with a
glass stopper. The tube was shaken vigorously on a shaking
apparatus for 15 min then centrifuged for 10 min to separate
the phases. Ten ml of the ethyl acetate phase were aspirated
into a clean tube. The ethyl acetate was evaporated to dryriess
at 45 ° C under a gentle stream of nitrogen. The residue was
dissolved in 100 methanol and mixed thoroughiy usiiig a
vortex. A 20 aliquot was injected into the liquid Chromato-
graph.
HPLCanalysis
After several trials, optimal Separation of the three compounds
was accomplished by eluting with 60 ml/l acetonitrile in 4 mmol/1
Phosphate buffer, pH 5.7. The flow rate was set at l ml/min.
The module chart speed was l cm/min.. Absorbance was moni-
tored at 237 nrn and recorded on the data module. Quantitäten
of peak areas using external Standard technique was carried out
using the data module Integrator. Internal Standard was found
unnecessary, because by repeated injectipns of the three com-
pounds into HPLC, reproducible resuits to within 4% were
constantly achieved, besides the simplicity and complete recov-
ery of the extraction procedure. ' f
Standard curve of actaminophen, salicylic acid
and salicyluric acid in pläsma and urine
Stock solution was prepared by dissolvirig 30 mg of ea^ch pf
acetaminophen, salieylic acid and salicyluric acid in 100 ml
distilled water. Working Standards were prepared by making
appropriate dilutions of the stock Standard- solution.
Differeht cpncentrations of each of the three compounds ranging
from 5 mg/1 to 50 mg/1 were added to drugsfree pläsma and
urine. Extraction for each sample was carried out äs rnentioned
before. A Standard curve was obtained by plotting the concentra-
tion of each sample agairist the peak area.
Urinary excretion of free acetaminophen, salicylic äcid
and salicyluric acid in man
Two healthy volunteers, 26 and 33 years old and weighirig 163
and 136 pounds (ca. 74 and ca. 62 kg) and with no histpry of
drug intake in the twelve week period preceding the test were
studied. Each volunteer was given an oral döse pf 650 mg Pf
äspirin® after an overnight fast. One hour later, each subject
was given 650 mg of acetaminophejn. No food was allowed up
to t wo hours äfter acetamiriPphen intake. Both volunteers were
allowed to drink water and fruit Juices to increase urine flow.
Ürine samples were collected from äspirin® admifiistfatipri every
l to 2 hours up to 12 hours, and at 24 hours. Urine samples
were filtered and pH and volume of each sample were deterr
mined. The samples were stored at - 30 ° C up till the time of
analysis.
Plasma concentration of free acetaminophen,
salicylic acid and salicyluric acid in man
Blood samples were taken every 15 min to l hour up to four
hours following drug administration. Each blood sample was
receiVed in a heparinized test tube and centrifuged. Plasma was
aspirated and stored at - 30 ° C up till the time of analysis.
Resuits and Discussion
The objective of this report is to develop a simple and
sensitive HPLC method for simultaneous Separation
and quantitation of acetaminophen, salicylic acid and
its main metabolite salicyluric acid in biological fluids.
Also, to evaluate previoüsly reported methodology for
these compounds (10,12-19). The method ofMiceli
et al. (20), which was carried out only on pläsma for
simultaneous measurement of acetaminophen and
salicylic acid lacks the complete Separation öf both
compounds due to their close retention times (2.15
and 2.90 min). The short retention times of both com-
pounds prevent their cleär Separation from the biologi-
cal background when this procedure is applied to urine
samples. In addition, this method did not describe
salicyluric acid determination. The method deyelbped
in our laboratory is simple, sensitive and cän be applied
for determination of both compounds and their metJl··
bölites in serum or üfirie in subtherapeutic, therapeutic or
toxic doses of each or both drugs. ;;
J. Cün. Chem. Cliii. Bipchem. / Vol. 20,1982 / No. 11
Douidar and Ahmed: Assay of acetaminophen, salicylic acid and salicyluric acid by HPLC 793
Optimization of extraction efficiency
Extraction solvent
Several solvents have been used for extraction of acet-
aminophen, salicylic acid and salicyluric acid. Levy &
Yamada (2) and others (12,13) used diethyl ether for
extraction of acetaminophen from plasma and urine
while Rowland & Riegelman (10) used the same solvent
for extraction of salicylic acid from plasma. Levy &
Procknal (21) used ethylene dichloride for extraction of
both salicylic acid and salicyluric acid from urine
samples. Miceli et al. (20) used a solvent mixture of
Chloroform and isopropanol l/l by volume for extrac-
tion of both acetaminophen and salicylic acid from
serum. In an attempt to develop one method of extrac-
tion of the three compounds from plasma and urine
simultaneously, we tried these solvents in addition to
ethyl acetate. Data in table l show the extraction
efficiency of these solvents to 10 mg/1 of each of acet-
aminophen, salicylic acid and salicyluric acid added to
drug-free plasma and urine. The same extraction proce-
dure was applied.for alPsolvent Systems used.
From plasma the extraction efficiency of ether for acet-
aminophen and salicyluric acid was found to be high,
however, for salicylic acid it was low. This indicates
that ether is not a gopd extraction solvent for salicylic
acid contrary to an earlier report (10). Ethylene di-
chloride has a very low extraction efficiency for acet-
aminophen and it was found that its capäbility for
extraction of both salicylic acid and salicyluric acid
lies within 50--55%f This may seem contradictory to the
previously reported methods considering ethylene di-
chloride äs an efficient extractor for these compounds.
This can be explaihed by the difference in pH of the
biological medium during extraction. Ethylene di-
chloride was used previously äs an extraction solvent at
very low pH (21) which allows more efficient extraction
for salicylic acid and salicyluric acid. This low pH may
be suitable for specirophotometric methods but we
observed in our HPLC analysis that at this low pH other
compounds were extracted äiid inteirfered with the com-
pounds under study. The extraction efficiency of ethyl
acetate from plasma at pH 2 was found to be high for
the three compounds without interference by any of the
biological compounds. Chloroform/isopropanol, l/l by
volume has a high extraction efficiency for acetamino-
phen, niode rate for salicylic acid and low for salicyluric
acid at this pH (tab. 1).
Frpm urine ether can extract acetaminophen with a high
efficiency at pH 5 but it has a low extraction efficiency
for salicylic acid at this pH. Ethylene dichloride has
a low extraction efficiency at pH 5 for the three
compounds. Ethyl acetate was found to have the
highest extraction efficiency for these three compounds.
Extraction from urine at pH 5 was found unreliable
for chloroform/isopropanol mixture due to inter-
ference by other compounds extracted with the test
compounds. As shown in table l, the extraction
efficiency of ethyl acetate for the three compounds
from plasma at pH 2 ranges from 98 to 104%. Recovery
of acetaminophen, salicylic acid and salicyluric acid
from urine at pH 5 was 98%, 87% and 87% respectively.
%
Effect ofpH of the biological medium
The pH of the biological medium affects to a great
extent the solventes extraction efficiency for these com-
pounds. Our study indicates that salicylic acid and
salicyluric acid are better extracted at a more acidic pH.
This is due to the minimum ionization of salicylic acid
at a pH below its pKa (3.0). Acetaminophen extraction
was found not to be greatly affected by changes in pH.
Data in table 2 show the extraction efficiency of ethyl
acetate for the three compounds at pH 2 and pH 5. As
shown the three compounds are completely extracted
from plasma at pH 2. Extraction at this pH can only be
applied to plasma due to no interference from biological
bäckground. However, in urine, äs shown in figure l,
extraction at pH 2 is unreliable due to the interference
by other compounds simultaneously extracted along
with these compounds. Repeated extractions of known
concentrations of the three compounds added to drug-
Tab. 1. Extraction efficiency (recovery, %, ± s) of various solvent Systems for acetaminophen, salicylic acid and salicyluric acid
from plasma (extraction at pH 2)) and urine (extraction at pÖ 5).
* vaiues obtained are unreliable due to interference by biological bäckground. ** less than 1% recovery.
Recovery (%)
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Tab. 2. Effcct of pH on the extraction efficiency of ethyl acetate for acetaminophen, salicylic acid and salicyluric acid front plasma,


































free urine at different pH indicated that at pH 5 extrac-
tion efficiency ranged from 87 to 98% for all com-
pounds studied. Minimal interference by other biological
materials was observed at this pH. Interestingly,Mce//
et al. reported (20) that they extracted acetaminophen
and salicylic acid at plasma pH (7.4). At that pH
salicylic acid is highly ionized and hence very weakly
soluble in organic solvents.
Optimization of the HPLC System condition
Effect of mobil&phase
Different mobile phases have been reported for the
Separation and quantitation of these compounds in^
dividually or in combination. When we tried one of these
mobile phases äs (methanol 9 g/l acetic acid; fractions
0.12/0.88) (22), a constant peak was observed having
the same retention time äs acetaminophen in the blank
biological samples. Hence, it interfered with acetamino-
phen determination. Under this condition, salicylic acid
and salicyluric acid have long retention times (tab. 3).
Tab. 3. Effect of mobile phase on the retention tirnes öf acet-

























































Refervt ion time [ m i n ]
Fig. l. Effect of pH on the extraction efficiency of ethyl acetate for acetaminophen, salicylic acid and salicyluric acid from urine.
a) Blank urine extract b) Extract of urine, spiked with 10 mg/1 each of acetaminophen, salicylic acid and salicyluric acid.
* values obtained are unreliable due to interference by other biological compounds.
+ extraction efficiencies for acetaminophen, salicylic acid and salicyluric acid äre 98 ± 2, 87 ± 4 and 87 ± 4 respectively.
-H- extraction efficiency for acetaminophen 97 ± 3, but for salicylic acid and salicyluric acid are less than fl.%.
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Using other mobile phases resulted in short retention
times for all compounds and overlapping by biological
background. For these reasons we tried to find a new
mobile phase that could clearly separate these com?
pounds without interference from other biological back-
ground. We found that 60 ml/1 acetonitrile in 4 mmol/1
phosphate buffer is an ideal mobile phase for this study.
Data in table 3 illustrate different mobile phases used
and the corresponding retention times of the three
compounds studied.
Effect ofpH of mobile phase
The retention time was found to be affected to a great
extent by the change in pH of mobile phase. It was ob-
served that the lower the pH the longer the retention
times of the three compounds studied. Increasing the
pH resulted in short retention times. Data in table 4
indicate that pH 5.7 is optimal for Separation of the
three compounds. Slight alteration such äs decimal
increase or decrease in the pH was found to alter the
retention times. Alteration of pH not only affects the
retention time but also chalnges the time intervals be-
tween the individual compounds. Therefore Separation
is affected.
Tab. 4. Effect of pH of mobile phase (acetonitrile, 60 ml/l in
4 mmol/1 phosphate buffer) on the retention times of


















Effect of UVdetector waive length
The previpus HPLC Systems used different wave lengths
for monitoring acetaminophen, salicylic acid or salicyl-
uric acid. A wave length of 300 nm was used (14,19)
for monitoring salicylic acid. Wave lengths ranging from
247 nm to 254 nm were used (12, 13, 20, 22) for
monitoring acetaminophen ör salicylic acid or footh. A
wave length 237 nm was used (16),fgr monitoring both
salicylic acid and salicylurie acid. In an ättempt to find
the UV wave length which provided maximum sensitivity
for these compounds, we compared the absorbäiice of
each compound separately and in combination with the
other twp compounds at various wave lengths. The data
in table 5 indicate that 237 nm is the most suitable wave
length for monitoring the three compounds simultane-
ously. For acetaminophen the highest absorbance was
observed at wave lengths 237 nm and 250 nm, whlle the
highest absorbances for salicylic acid and salicyluric acid
were observed at 237 nm. Hence, those previous methods
which monitored these last two compounds at wave
lengths other than 237 nm lacked the maximum sensi-
tivity and probably underestimated these compounds
especially at low concentrations.
The retention times for salicylic acid, salicyluric acid
and acetaminophen were 5.7, 7.4 and 9.7 min respec- ·
tively. Figure 2a shows a chromatogram of a human
plasrna blank at pH 2 after extraction by ethyl acetate.
Figure 2b shows a chromatogram of a human plasma
blank spiked with 10 g each of acetaminophen, salicylic
acid and salicyluric acid and extracted äs described
before. Figure 2c shows a chromatogram of a human




Fig. 2. High performance liquid chromatqgram of human plasma
extract: (a) blank plasma, (b) plasma spiked with 10 mg/1
each of salicylic acid, salicyluric acid and acetaminophen
and (c) human plasma sample 1.5 hour after 650 mg
aspirin^ and 0.5 hour after the same dose of acetamino-
phen.
Tab. 5. Absörbance and peak areas of 10 mg/1 each of acetamino-
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after the same dose for acetaminophen. Figure 3a shows
a chromatogram of a human urine blank extracted at
pH 5. Figure 3b illustrates the same Standards added
to drug-free urine and extracted. Figure 3c shows a
chromatogram of a human urine sample 2 h after
650 mg each of aspirin and acetaminophen. As shown,
chromatograms from blank plasma yielded an extraneous
peak aro nd 3.5 min, while chromatograms from blank
urine produce peaks between 3.5 and 4.7 min. None of







12 3 6 9 12
Fig. 3. High performance liquid chromatogram of human urine extract: (a) blank urine, (b) -urine spiked with 10 mg/1 each of
salicylic acid, salicyluric acid and acetaminophen and (c) human urine sample 2.0 hours after 650 mg of aspirin® and 1.0 hour
after the same dose of acetaminophen.
Accuracy and precision of this method for acetamino-
phen, salicylic acid and salicyluric acid in human plasma
and urine are shown in tables 6 and 7. The three com-
pounds were added to drug-free plasma and urine in
concentrations ranging from 5 to 50 mg/1 each and
extracted s described before. The Standard curves
show a linear relationship between the cpncentrations
and peak areas over these ranges. The Coefficient of
Variation of these results is less than 4% in all concentra-
tions studied. Cpncentratioris lower or higher than this
Tab. 6. Recovery of acetaminophen, salicylic acid and salicyluric acid after extraction from plasma at pH 2. Coefficient of Variation
is less than 4% over these concentrations.
































































103 ± 1. 8
Tab. 7. Recovery of acetaminophen, salicylic acid and salicyluric acid after extraction from urine at pH 5. Coefficient of Variation is
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r nge can be estimated with the same efficiency by
changing the sample or methanol volumes or by changing
the UV detector sensitivity.
This method was used to study the urinary excretion in
24 h of free acetaminophen, salicyiic acid and salicyluric
acid in two healthy human volunteers who ingested
650 mg of aspirin® followed l h later by 650 mg of
acetaminophen. Figure 4 illustrates the excretion of the
three compounds in g/l at various times. As shown,
acetaminophen concentration in urine was at its highest
level 1-2 hours after drug administration. Salicyiic acid
and salicyluric acid reached their highest concentration
level within 3 to 4 hours following drug administration.
From this study we observed that the amount of free
acetaminophen excreted in 24 hours accounts for 3.6
to 4.5% of acetaminophen dose. Salicyiic acid accounts
for 6.2 to 9.5% of the aspirin® dose while salicyluric
acid excretion accounts for 59 to 60% of the aspirin®
dose. These figures agree with other reports (5, 23).
i r Ί l L
16 18 20 22 24
2 4 6 8 10 12 14 16 18 20 22 24
2 4 6 8 10 12 14 16 18 20 22 24
Fig. 4. Twenty-f our hour excretion of acetaminophen (a),
salicyiic acid (b) and salicyluric acid (c) in two human
subjects after a single dose (650 mg) each of aspirin®
and acetaminophen.
This method was also used to study the plasma con-
centrations of the three compounds for the same
volunteers who ingested the previous doses of both
aspirinB and acetaminophen. Blood samples were col-
lected every 15 min to l hour up to 4 hours following
drug administration. Figure 5 illustrates the plasma
concentration versus time of each compound. As shown,
the highest plasma concentration of acetaminophen
which is 11 mg/1 was obtained 0.5 hour after drug
administration. Salicyiic acid and salicyluric acid have
their highest plasma concentrations (35 mg/1 and
2.8 mg/1 respectively) about 1.5 hour after oral aspirin®
administration. The plasma concentrations of the three
compounds over 4 hours in our study are in agreement
with results presented by Levy et al. (24).
t [h]
Fig. 5. Plasma concentration of, salicylic acid Δ—Δ, salicyluric
acid o—o and acetaminophen o—α over four hours after
a single dose (650 mg).each of aspirin® and acetamino-
phen.
In summary, this HPLC method is simple and reliable
for determination and quantitation of acetaminophen,
salicylic acid and salicyluric acid in biological fluids.
This method is highly sensitive and can detect and
quantitate each of the three compounds in a concentra-
tion up to l mg/1. The three compounds can be extracted
by one solvent and separated during one run in HPLC.
A single run lasts only for 15 minutes. This method can
also be used for determination of other salicylates and
acetaminophen metabolites after acid or enzymatic
hydrolysis of these conjugates to the free compound
(2, 21). We are currently using this method for pharma-
c kinetic and pharmacodynamic studies of a combina-
tion of acetaminophen and salicylates in human.
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